Misplaced Pages

Felvizumab

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

Monoclonal antibody Pharmaceutical compound

Felvizumab
Monoclonal antibody
Type	Whole antibody
Source	Humanized (from mouse)
Target	RSV
Clinical data
ATC code	none
Identifiers
CAS Number	167747-20-8
ChemSpider	none
UNII	W9ZA2K5Q83
KEGG	D04136
(what is this?) (verify)

Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus.

References

"WHO Drug Information" (PDF). Archived from the original (PDF) on February 23, 2012.
Milne GW (2018). "6591: Felvizumab". Drugs synonyms and properties. London: Routledge Revivals. ISBN 978-1-351-78989-9.

v
t
e

Monoclonal antibodies for infectious disease and toxins

Human	Efungumab

Human	Ansuvimab Atoltivimab (+maftivimab/odesivimab) Avdoralimab Bamlanivimab (+etesevimab) Bebtelovimab Casirivimab (+imdevimab) Cilgavimab (+tixagevimab) Diridavumab Etesevimab Exbivirumab Foravirumab Imdevimab (+casirivimab) Libivirumab Maftivimab Nirsevimab Odesivimab Pemivibart Rafivirumab Regavirumab Regdanvimab Sevirumab Sipavibart Sotrovimab Suptavumab Tixagevimab (+cilgavimab) Tuvirumab
Chimeric	Cosfroviximab Larcaviximab Porgaviximab Vilobelimab
Humanized	Felvizumab Lenvervimab Motavizumab Palivizumab Suvizumab

Human	Nebacumab Panobacumab Raxibacumab
Mouse	Edobacomab
Chimeric	Pagibaximab
Humanized	Tefibazumab

Human	Actoxumab Bezlotoxumab Suvratoxumab
Chimeric	Obiltoxaximab
Humanized	Urtoxazumab

WHO-EM
Withdrawn from market
Clinical trials:
- Phase III
- Never to phase III

This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it.

v
t
e

This monoclonal antibody–related article is a stub. You can help Misplaced Pages by expanding it.

v
t
e